LivaNova PLC (LIVN) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products, such as cardiopulmonary and respiratory support solutions. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.
the bull case· 4
4
disclosed supplier and customer ties in SEC filings
sec filingsedgar31
managers whose positions together make up four fifths of the reported value
13fJun 30 '26+12.66%
change in shares held by the ten largest reporting managers over the latest quarter
13fJun 30 '26301
managers reporting a position in thirteen F filings
13fJun 30 '26the bear case· 3
3 of 8
recent reports where the move came in under the options implied range
earnings historyimplied vs realized3
of the funds on file reporting a position in LIVN
n-portas of Jun 30 '266 of 24
of the largest reporting managers cut their stake in the latest quarter
13fJun 30 '26Sides and captions by the model; every figure is ours. Built Sep 16 '26 for the Nov 4 '26 report. Not a forecast, not advice.
LivaNova PLC
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Electromedical & Electrotherapeutic Apparatus
High 78.08 at 2:45 pm ET, low 76.99 at 10:15 am ET.
Of the 6 companies LivaNova PLC moves with most closely, none share its SEC classification.
Measured against 499 trading days of our own closes. Co-movement, not cause.
SIC 3845, Electromedical & Electrotherapeutic Apparatus, from each company's own filings. Largest first.
LIVN (LivaNova PLC) has 4 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.
tall tick = annual report · 1 on record
301 managers report a position worth $4.9B between them, and 31 of them hold 80% of it.